The NOX family of NADPH oxidases is an important source of reactive oxygen species, of which Nox4 is most abundantly expressed in the kidney, and is therefore not only known as the renal NADPH oxidase (Renox), but also as a new therapeutic target for vascular complications of diabetes (108, 109). Here, FMO5 is linked to diabetes mellitus.